EAHAD

AcronymDefinition
EAHADEuropean Association for Haemophilia and Allied Disorders
References in periodicals archive ?
About the A-LONG (rFVIIIFc) Data at EAHAD The A-LONG results confirm the long-lasting characteristics of rFVIIIFc; specifically, the data show that rFVIIIFc stays in the body for 50 percent longer than Advate([R]) [antihemophilic factor (recombinant), plasma/albumin-free method], the most frequently used factor VIII therapy.
About the B-LONG (rFIXFc) Data at EAHAD The B-LONG results confirm the long-lasting characteristics of rFIXFc; specifically, the data show that rFIXFc stays in the body for more than twice as long as BeneFIX([R]) [Coagulation Factor IX (Recombinant)], the only recombinant factor IX therapy currently approved for prophylactic use.